Nalaganje...

Androgen receptor decoy molecules block the growth of prostate cancer

The androgen receptor (AR) is activated by both ligand-dependent and -independent mechanisms. Current therapies for prostate cancer target the ligand-binding domain in the C terminus of the AR. However, ligand-independent activation of the AR occurs by the N-terminal domain (NTD), making the NTD a p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Quayle, Steven N., Mawji, Nasrin R., Wang, Jun, Sadar, Marianne D.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2007
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1783142/
https://ncbi.nlm.nih.gov/pubmed/17227854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0606718104
Oznake: Označite
Brez oznak, prvi označite!